AFP and hepatocellular carcinoma: One specific modification, core fucosylation, has been observed in non-small cell lung carcinoma (NSCLC), ovarian cancer, and colon cancer and is used clinically in the diagnosis of hepatocellular carcinoma (HCC) in the form of the AFP-L3 assay50, 51, 52, 53.